FI913324A0 - Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi

Info

Publication number
FI913324A0
FI913324A0 FI913324A FI913324A FI913324A0 FI 913324 A0 FI913324 A0 FI 913324A0 FI 913324 A FI913324 A FI 913324A FI 913324 A FI913324 A FI 913324A FI 913324 A0 FI913324 A0 FI 913324A0
Authority
FI
Finland
Prior art keywords
heteroaryl
acyl
preparation
therapeutically useful
alkyl
Prior art date
Application number
FI913324A
Other languages
English (en)
Swedish (sv)
Other versions
FI92827C (fi
FI92827B (fi
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI913324A0 publication Critical patent/FI913324A0/fi
Application granted granted Critical
Publication of FI92827B publication Critical patent/FI92827B/fi
Publication of FI92827C publication Critical patent/FI92827C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI913324A 1989-01-10 1991-07-09 Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi FI92827C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8900079 1989-01-10
PCT/US1989/000079 WO1990008145A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles

Publications (3)

Publication Number Publication Date
FI913324A0 true FI913324A0 (fi) 1991-07-09
FI92827B FI92827B (fi) 1994-09-30
FI92827C FI92827C (fi) 1995-01-10

Family

ID=22214772

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913324A FI92827C (fi) 1989-01-10 1991-07-09 Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0378358B1 (fi)
JP (1) JPH0692400B2 (fi)
KR (1) KR920006785B1 (fi)
AT (1) ATE96793T1 (fi)
AU (1) AU616336B2 (fi)
CA (1) CA2007655C (fi)
DE (1) DE69004272T2 (fi)
DK (1) DK0378358T3 (fi)
ES (1) ES2060007T3 (fi)
FI (1) FI92827C (fi)
HU (1) HU215112B (fi)
IE (1) IE62143B1 (fi)
IL (1) IL92962A (fi)
NO (1) NO179103C (fi)
NZ (1) NZ232039A (fi)
PT (1) PT92800B (fi)
WO (1) WO1990008145A1 (fi)
ZA (1) ZA90139B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886541A1 (en) 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
CN108456205B (zh) * 2018-05-21 2021-06-04 深圳市众康动保科技有限公司 一种3,3二取代羟基吲哚化合物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
GR850310B (fi) * 1984-02-07 1985-06-05 Pfizer
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
IN163263B (fi) * 1984-02-07 1988-08-27 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4695571A (en) * 1984-08-24 1987-09-22 Pfizer Inc. Tricyclic oxindole antiinflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
NO912694L (no) 1991-07-09
DE69004272T2 (de) 1994-02-24
DK0378358T3 (da) 1993-12-06
KR920006785B1 (ko) 1992-08-17
ES2060007T3 (es) 1994-11-16
PT92800A (pt) 1990-07-31
CA2007655C (en) 1996-10-22
CA2007655A1 (en) 1991-07-12
ATE96793T1 (de) 1993-11-15
AU616336B2 (en) 1991-10-24
ZA90139B (en) 1991-08-28
FI92827C (fi) 1995-01-10
WO1990008145A1 (en) 1990-07-26
IE62143B1 (en) 1994-12-14
NO179103C (no) 1996-08-07
HUT62292A (en) 1993-04-28
JPH02270868A (ja) 1990-11-05
NO179103B (no) 1996-04-29
NO912694D0 (no) 1991-07-09
IL92962A (en) 1995-01-24
AU4781690A (en) 1990-07-19
DE69004272D1 (de) 1993-12-09
JPH0692400B2 (ja) 1994-11-16
NZ232039A (en) 1991-07-26
EP0378358A1 (en) 1990-07-18
FI92827B (fi) 1994-09-30
HU215112B (hu) 1998-12-28
KR900011762A (ko) 1990-08-02
EP0378358B1 (en) 1993-11-03
IE900075L (en) 1990-07-10
PT92800B (pt) 1995-12-29

Similar Documents

Publication Publication Date Title
FI113619B (fi) Menetelmä injektoitavien taksaanijohdannaisiin pohjautuvien koostumusten valmistamiseksi
NO20011721L (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5- reseptoren
MX9805291A (es) Derivados de feniltiazol con propiedades anti-virus de herpes.
DE60026404D1 (de) Verfahren zur Herstellung von Benzothiophen-Derivaten
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
FI954994A (fi) 3-(het)aryylikarboksyylihappojohdannaiset, menetelmä ja välituotteet niiden valmistamiseksi
FI913324A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi
BR9612196A (pt) Tiazolinas substituidas
NZ309499A (en) Styryl benzimidazole derivatives useful as inhibitors of smooth muscle cell proliferation
NO178193C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-heteroaryloksindol-3-karboksamider
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
IE33218B1 (en) Benzodiazepine derivatives
IE42068L (en) Naphthopyran and benzodipyran 2-carboxylic acids
IE38064B1 (en) New 2-amino-4h-pyrane compounds their production and their medicinal use
GB9512005D0 (en) Slip casting
TW366344B (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
KR927003511A (ko) 5-리폭시게나제 억제제로서의 2-아릴메틸-1-나프톨 유도체의 에스테르

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired